Engineering natural products using combinatorial biosynthesis and biocatalysis

Current Opinion in Biotechnology

Volumn 19, Issue 6, 2008, Pages 590-596

  Zhou, Hui ^a   Xie, Xinkai ^a   Tang, Yi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; BIOSYNTHESIS; CATALYSTS; PROTEINS;

BIOCATALYSIS; BIOSYNTHETIC PATHWAYS; COMBINATORIAL BIOSYNTHESES; HOST ORGANISMS; NATURAL PRODUCTS; PHARMACOLOGICAL PROPERTIES; STRUCTURAL VARIATIONS; SYNTHESIS OF;

ENZYMES;

ARTEMISINIC ACID; DAPTOMYCIN; DAUNORUBICIN; EPOTHILONE A; EPOTHILONE D; ERYTHROMYCIN; ERYTHROMYCIN C; FLUOROSALINOSPROMIDE; GLYCOSYLTRANSFERASE; LIPOPEPTIDE; MACROLIDE; MEVINOLIN; MITHRAMYCIN; MORPHINE; NATURAL PRODUCT; PIKROMYCIN; RAPAMYCIN; RETICULINE; SALINOSPORAMIDE A; SIMVASTATIN; TYROCIDINE; UNCLASSIFIED DRUG;

ACYLATION; BIOCATALYST; BIOSYNTHESIS; CATALYSIS; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; GENE CLUSTER; GENETIC ENGINEERING AND GENE TECHNOLOGY; GENOMICS; GLYCOSYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

BIOCATALYSIS; BIOLOGICAL PRODUCTS; COMBINATORIAL CHEMISTRY TECHNIQUES; PHARMACEUTICAL PREPARATIONS;

EID: 57049185719     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2008.10.012     Document Type: Review

References (50)

1. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25 (2008) 475-516
2. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70 (2007) 461-477
3. Bergmann S., Schumann J., Scherlach K., Lange C., Brakhage A.A., and Hertweck C. Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat Chem Biol 3 (2007) 213-217
4. Udwary D.W., Zeigler L., Asolkar R.N., Singan V., Lapidus A., Fenical W., Jensen P.R., and Moore B.S. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc Natl Acad Sci U S A 104 (2007) 10376-10381
5. Debono M., Abbott B.J., Molloy R.M., Fukuda D.S., Hunt A.H., Daupert V.M., Counter F.T., Ott J.L., Carrell C.B., Howard L.C., et al. Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). J Antibiot (Tokyo) 41 (1988) 1093-1105
6. Raja A., LaBonte J., Lebbos J., and Kirkpatrick P. Daptomycin. Nat Rev Drug Discov 2 (2003) 943-944
7. Schwarzer D., Finking R., and Marahiel MA. Nonribosomal peptides: from genes to products. Nat Prod Rep 20 (2003) 275-287
8. Milne C., Powell A., Jim J., Al Nakeeb M., Smith C.P., and Micklefield J. Biosynthesis of the (2S, 3R)-3-methyl glutamate residue of nonribosomal lipopeptides. J Am Chem Soc 128 (2006) 11250-11259
9. Nguyen K.T., Kau D., Gu J.Q., Brian P., Wrigley S.K., Baltz R.H., and Miao V. A glutamic acid 3-methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus. Mol Microbiol 61 (2006) 1294-1307
10. Powell A., Al Nakeeb M., Wilkinson B., and Micklefield J. Precursor-directed biosynthesis of nonribosomal lipopeptides with modified glutamate residues. Chem Commun (2007) 2683-2685
11. Baltz R.H., Miao V., and Wrigley S.K. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep 22 (2005) 717-741
12. Miao V., Coeffet-Le Gal M.F., Nguyen K., Brian P., Penn J., Whiting A., Steele J., Kau D., Martin S., Ford R., et al. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics. Chem Biol 13 (2006) 269-276
13. Nguyen K.T., Ritz D., Gu J.Q., Alexander D., Chu M., Miao V., Brian P., and Baltz R.H. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc Natl Acad Sci U S A 103 (2006) 17462-17467. This paper employed multiple strategies towards the combinatorial biosynthesis of daptomycin, including module replacement and subunit exchange. As a result, a library of novel lipopeptides was generated in vivo and the biological activities were screened.
14. Powell A., Borg M., Amir-Heidari B., Neary J.M., Thirlway J., Wilkinson B., Smith C.P., and Micklefield J. Engineered biosynthesis of nonribosomal lipopeptides with modified fatty acid side chains. J Am Chem Soc 129 (2007) 15182-15191
15. Khosla C., Tang Y., Chen A.Y., Schnarr N.A., and Cane D.E. Structure and mechanism of the 6-deoxyerythronolide B synthase. Annu Rev Biochem 76 (2007) 195-221
16. Boddy C.N., Hotta K., Tse M.L., Watts R.E., and Khosla C. Precursor-directed biosynthesis of epothilone in Escherichia coli. J Am Chem Soc 126 (2004) 7436-7437
17. Ashley G.W., Burlingame M., Desai R., Fu H., Leaf T., Licari P.J., Tran C., Abbanat D., Bush K., and Macielag M. Preparation of erythromycin analogs having functional groups at C-15. J Antibiot (Tokyo) 59 (2006) 392-401
18. Gregory M.A., Petkovic H., Lill R.E., Moss S.J., Wilkinson B., Gaisser S., Leadlay P.F., and Sheridan R.M. Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis. Angew Chem Int Edit 44 (2005) 4757-4760
19. Gupta S., Lakshmanan V., Kim B.S., Fecik R., and Reynolds K.A. Generation of novel pikromycin antibiotic products through mutasynthesis. Chembiochem 9 (2008) 1609-1616
20. Cortes J., Haydock S.F., Roberts G.A., Bevitt D.J., and Leadlay P.F. An unusually large multifunctional polypeptide in the erythromycin-producing polyketide synthase of Saccharopolyspora erythraea. Nature 348 (1990) 176-178
21. Pfeifer B.A., Admiraal S.J., Gramajo H., Cane D.E., and Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291 (2001) 1790-1792
22. Peiru S., Menzella H.G., Rodriguez E., Carney J., and Gramajo H. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microb 71 (2005) 2539-2547
23. Lee H.Y., and Khosla C. Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli. PLoS Biol 5 (2007) e45
24. Menzella H.G., Reid R., Carney J.R., Chandran S.S., Reisinger S.J., Patel K.G., Hopwood D.A., and Santi D.V. Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes. Nat Biotechnol 23 (2005) 1171-1176
25. Mutka S.C., Carney J.R., Liu Y.Q., and Kennedy J. Heterologous production of epothilone C and D in Escherichia coli. Biochemistry-US 45 (2006) 1321-1330
26. Feling R.H., Buchanan G.O., Mincer T.J., Kauffman C.A., Jensen P.R., and Fenical W. Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora. Angew Chem Int Ed Engl 42 (2003) 355-357
27. McGlinchey R.P., Nett M., Eustaquio A.S., Asolkar R.N., Fenical W., and Moore B.S. Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors. J Am Chem Soc 130 (2008) 7822-+
28. Eustaquio A.S., and Moore B.S. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. Angew Chem Int Ed Engl 47 (2008) 3936-3938
29. Martin V.J.J., Pitera D.J., Withers S.T., Newman J.D., and Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21 (2003) 796-802
30. Chang M.C.Y., Eachus R.A., Trieu W., Ro D.K., and Keasling J.D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3 (2007) 274-277. A plant cytochrome P450 was successfully implanted in an E. coli host to functionalize a precursor of artemisinin. The microorganism host produced the key intermediate artemisinic acid.
31. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440 (2006) 940-943
32. Minami H., Kim J.S., Ikezawa N., Takemura T., Katayama T., Kumagai H., and Sato F. Microbial production of plant benzylisoquinoline alkaloids. Proc Natl Acad Sci U S A 105 (2008) 7393-7398. An advanced microbial system for the synthesis of alkaloids was developed in this work. First, the authors synthesized (S)-reticuline in an engineered E. coli strain. This intermediate was then supplemented into a recombinant S. cerevisiae culture to produce benzylisoquinoline alkaloids.
33. Hawkins K.M., and Smolke C.D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat Chem Biol 4 (2008) 564-573
34. Trauger J.W., Kohli R.M., Mootz H.D., Marahiel M.A., and Walsh C.T. Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase. Nature 407 (2000) 215-218
35. Trauger J.W., Kohli R.M., and Walsh C.T. Cyclization of backbone-substituted peptides catalyzed by the thioesterase domain from the tyrocidine nonribosomal peptide synthetase. Biochemistry-US 40 (2001) 7092-7098
36. Kohli R.M., Trauger J.W., Schwarzer D., Marahiel M.A., and Walsh C.T. Generality of peptide cyclization catalyzed by isolated thioesterase domains of nonribosomal peptide synthetases. Biochemistry-US 40 (2001) 7099-7108
37. Lin H., Thayer D.A., Wong C.H., and Walsh C.T. Macrolactamization of glycosylated peptide thioesters by the thioesterase domain of tyrocidine synthetase. Chem Biol 11 (2004) 1635-1642
38. Kohli R.M., Walsh C.T., and Burkart M.D. Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418 (2002) 658-661
39. Yeh E., Lin H.N., Clugston S.L., Kohli R.M., and Walsh C.T. Enhanced macrocyclizing activity of the thioesterase from tyrocidine synthetase in presence of nonionic detergent. Chem Biol 11 (2004) 1573-1582
40. Sieber S.A., Tao J.H., Walsh C.T., and Marahiel M.A. Peptidyl thiophenols as substrates for nonribosomal peptide cyclases. Angew Chem Int Edit 43 (2004) 493-498
41. Zhang C.S., Griffith B.R., Fu Q., Albermann C., Fu X., Lee I.K., Li L.J., and Thorson J.S. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Science 313 (2006) 1291-1294. This paper described a general method to generate a large number of glycosylated natural product derivatives by reversible glycosyltransferases. These biocatalysts were able to synthesize a large library of glycosylated natural products through aglycon:TDP-sugars exchange and aglycon:aglycon sugar exchange.
42. Zhang C.S., Albermann C., Fu X., and Thorson J.S. The in vitro characterization of the iterative avermectin glycosyltransferase AveBI reveals reaction reversibility and sugar nucleotide flexibility. J Am Chem Soc 128 (2006) 16420-16421
43. Williams G.J., Zhang C., and Thorson J.S. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat Chem Biol 3 (2007) 657-662
44. Williams G.J., Goff R.D., Zhang C.S., and Thorson J.S. Optimizing glycosyltransferase specificity via 'Hot spot' saturation mutagenesis presents a catalyst for novobiocin glycorandomization. Chem Biol 15 (2008) 393-401
45. Loncaric C., Merriweather E., and Walker K.D. Profiling a taxol pathway 10 beta-acetyltransferase: assessment of the specificity and the production of baccatin III by in vivo acetylation in E-coli. Chem Biol 13 (2006) 309-317
46. Freeman M.W. Statins, cholesterol, and the prevention of coronary heart disease. FASEB J 20 (2006) 200-201
47. Xie X.K., Watanabe K., Wojcicki W.A., Wang C.C.C., and Tang Y. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chem Biol 13 (2006) 1161-1169. An acyltransferase was characterized in this paper towards the biosynthesis of lovastatin analogues, including the semisynthetic simvastatin. This enzyme displayed broad substrate specificity towards the acyl carrier, the acyl substrate and the decalin core. Whole-cell biocatalysis was implemented to synthesize simvastatin from monacolin J.
48. Xie X.K., and Tang Y. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microb 73 (2007) 2054-2060
49. Xie X.K., Wong W.W., and Tang Y. Improving simvastatin bioconversion in Escherichia coli by deletion of bioH. Metab Eng 9 (2007) 379-386
50. Xie X.K., Pashkov I., Gao X., Guerrero J.L., Yeates T.O., and Tang Y. Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity. Biotechnol Bioeng (2008) 10.1002/bit.22028